Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elidel cream for head and neck atopic dermatitis in patients intolerant of topical corticosteroids
2004-001036-23Phase 4Completed
- Sponsor
- Novartis
- Start
- Oct 2004
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in atopic dermatitis (AD) comparing Elidel then open-label Elidel with Vehicle then open-label Elidel (2 arms). Primary endpoint: Facial Investigator's Global Assessment at week 6. Started Oct 2004; status: completed.
02
Drugs
pimecrolimus
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2004-001036-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001036-23.